Established in 1988, Mitsubishi Kagaku Bio-Clinical Laboratories (MBC) has nearly 20 years’ experience of clinical testing and drug development supporting services in Japan.
In the Main Reference Laboratory, operated under GCLP regulation, approximately 500,000 tests are carried out every day. In order to meet the increasing requirements of clinical trials, MBC opened its clinical laboratory dedicated to clinical trials, the C-Lab, which is the first and the only central laboratory in Japan. C-Lab has features including:
- Continuous test methods
- Long-term data storage
- 21 CFR part 11 consistency
MBC also provides bioanalysis services under GLP regulation. MBC harbours state-of-the-art instruments such as 20 LC-MS instruments including API5000 as well as abundant know-how as to the sample treatment.
With these solid and integrated services, MBC can confidently support you in all aspects of drug development.